BioLineRx (BLRX) Receivables - Net (2010 - 2025)

BioLineRx's (BLRX) quarterly Receivables - Net came in at $46000.0 in Q4 2025, down 98.14% year-on-year from $2.5 million in Q4 2024, and down 41.03% quarter-over-quarter from $78000.0 in Q2 2025.

BioLineRx (BLRX) Receivables - Net (2010 - 2025) Analysis & Trends

BioLineRx's Receivables - Net history runs 5 years deep, the most recent figure standing at $46000.0 for Q4 2025.

  • On a quarterly basis, Receivables - Net fell 98.14% year-over-year to $46000.0 in Q4 2025; TTM through Dec 2025 was $46000.0, a 98.14% decrease from a year earlier, with the FY2025 full-year figure at $46000.0, down 98.14% from the prior year.
  • Receivables - Net retreated to $46000.0 in Q4 2025 per BLRX's latest filing, from $78000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $3.6 million in Q3 2024 and bottomed at $46000.0 in Q4 2025.
  • The 3-year median for Receivables - Net is $2.0 million (2024), against an average of $1.8 million.
  • Across the five-year window, Receivables - Net jumped 591.62% in 2024 and slumped 98.14% in 2025, its largest moves.
  • Year by year, Receivables - Net stood at $358000.0 in 2023, then soared by 591.62% to $2.5 million in 2024, then slumped by 98.14% to $46000.0 in 2025.
  • Per Business Quant, the three latest BLRX Receivables - Net figures stand at $46000.0 (Q4 2025), $78000.0 (Q2 2025), and $1.5 million (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 BioLineRx 7.05 Bn 7.06 Bn 154,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 46,000.00
Dec 31, 2025 46,000.00
Jun 30, 2025 78,000.00
Jun 30, 2025 78,000.00
Mar 31, 2025 1.47 Mn
Mar 31, 2025 1.47 Mn
Dec 31, 2024 2.48 Mn
Dec 31, 2024 2.48 Mn
Sep 30, 2024 3.61 Mn
Sep 30, 2024 3.61 Mn
Jun 30, 2024 3.18 Mn
Jun 30, 2024 3.18 Mn
Mar 31, 2024 2.83 Mn
Mar 31, 2024 2.83 Mn
Dec 31, 2023 358,000.00
Dec 31, 2023 358,000.00
Jun 30, 2011 5.09 Mn
Jun 30, 2011 5.09 Mn
Dec 31, 2010 5.29 Mn
Dec 31, 2010 5.29 Mn